CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2024
Operating activities:
Net earnings	$ 601	$ 824	$ 292
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	247	219	235
Stock-based compensation	48	81	74
Deferred income taxes	81	(18)	(100)
Venture agreement payment	476	0	0
Loss on divestiture	0	112	238
Pension settlement charge	0	0	171
Other	(7)	(26)	26
Changes in:
Receivables, net	151	(145)	(34)
Inventories, net	(71)	63	55
Prepaid expenses and other current assets	2	(9)	25
Accounts payable and accrued liabilities	38	(124)	(140)
Operating lease right-of-use assets and liabilities, net	(4)	2	0
Income taxes payable/prepaid	2	2	(147)
Net cash provided by operations	612	981	695
Investing activities:
Capital expenditures	(207)	(220)	(212)
Business acquired, net of cash acquired	(2,104)	0	0
Proceeds from divestiture, net of cash divested	0	128	17
Other	10	(2)	20
Net cash used for investing activities	(2,301)	(94)	(175)
Financing activities:
Notes and loans payable, net	1,078	0	(45)
Debt borrowings, net of issuance costs paid	2,737	0	0
Debt repayments	(1,250)	0	0
Treasury stock purchased	(256)	(332)	0
Cash dividends paid to Clorox stockholders	(602)	(602)	(595)
Cash dividends paid to noncontrolling interests	(16)	(16)	(16)
Issuance of common stock for employee stock plans and other	(23)	26	1
Net cash provided by (used for) financing activities	1,668	(924)	(655)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2)	0	(26)
Net increase (decrease) in cash, cash equivalents and restricted cash	(23)	(37)	(161)
Cash, cash equivalents and restricted cash:
Beginning of year	170	207	368
End of year	147	170	207
Supplemental cash flow information:
Interest paid	122	97	102
Income taxes paid, net of refunds	104	264	347
Noncash financing activities:
Cash dividends declared and accrued, but not paid	$ 16	$ 16	$ 16